Galmed pharmaceuticals reports q1 2020 financial results

Galmed pharmaceuticals provides business update and reports first quarter 2020 financial results.q1 loss per share $0.29.q1 earnings per share estimate $-0.37 -- refinitiv ibes data.galmed pharmaceuticals - making certain adjustments to clinical staff pay according to current and predicted level of activity.reducing directors' cash fees by 50% for first half of 2020.
GLMD Ratings Summary
GLMD Quant Ranking